Company Analysis - CSL Ltd.
RNCOS
January 1, 2012 35 Pages - SKU: CICQ6750130
|
|
Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.
The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.
The report is an outcome of extensive research and makes use of data provided by various credible publications, trade journals, industry associations, and the company sources.
Report Highlights
- Provides a comprehensive version of the company's performance
- Offers key financial data, ratio and SWOT analysis
- Tracks major M&A trends and developments
- Business Profile, SWOT analysis and financial information on top competitors
- View on the company by our analysts
- Supplemented with graphs and tabular information wherever necessary
|
- 1. Company Overview
- 1.1 History
- 1.2 Business Overview
- 1.3 Organizational Structure
- 1.4 Major Mergers & Acquisitions
- 1.5 Ticker Codes at Various Stock Exchange Listings
- 1.6 Management Profile
- 2. Product & Services
- 2.1 Product & Services - An Overview
- 2.2 Revenue Summary by Geographical Distribution
- 3. Financial Information for the Fiscal Year
- 3.1 Financial Summary for the Fiscal Year
- 3.2 Breakup of Revenue & Sales Trends
- 3.3 Ratio & Market Indicators
- 3.4 Earnings & Income Estimates
- 3.5 Stock Analysis
- 4. SWOT Analysis
- 4.1 Strengths
- 4.2 Weaknesses
- 4.3 Opportunity
- 4.4 Threats
- 5. Top Competitors (Key Financials & SWOT Analysis)
- 5.1 GlaxoSmithKline Plc.
- 5.2 AstraZeneca Plc.
- 5.3 Merck & Co., Inc.
- 5.4 Daiichi Sankyo Company Ltd.
- 6. Analyst View
- List of Figures:
- Figure 2-1: CSL Ltd. - Revenue by Geographical Distribution (Million US$), FY 2010 & FY 2011
- Figure 3-1: CSL Ltd. - Stock Chart
- List of Tables:
- Table 1-1: CSL Ltd. - Major Mergers & Acquisitions (2006)
- Table 1-2: CSL Ltd. - Ticker Codes at various Stock Exchange
- Table 1-3: CSL Ltd. - Key Management People
- Table 3-1: CSL Ltd. - Financial Overview (Million US$), FY 2011
- Table 3-2: CSL Ltd. - Breakup of Revenue & Sales (Million US$), FY 2009 to FY 2011
- Table 3-3: CSL Ltd. - Key Financial Ratios (FY 2009 to FY 2011)
- Table 3-4: CSL Ltd. - Earnings & Income Estimates (Million US$), FY 2009 to FY 2011
- Table 5-1: GlaxoSmithKline Plc. - Key Financials (Million US$), 2008-2010
- Table 5-2: GlaxoSmithKline Plc. - SWOT Analysis
- Table 5-3: AstraZeneca Plc. - Key Financials (Million US$), 2008-2010
- Table 5-4: AstraZeneca Plc. - SWOT Analysis
- Table 5-5: Merck & Co., Inc. - Key Financials (Million US$), 2008-2010
- Table 5-6: Merck & Co., Inc. - SWOT Analysis
- Table 5-7: Daiichi Sankyo Company Ltd. - Key Financials (Million US$), FY 2009 to FY 2011
- Table 5-8: Daiichi Sankyo Company Ltd. - SWOT Analysis
Share this report
Other tasks Related Markets Pharmaceuticals Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
